Equilibrium CT Texture Analysis for the Evaluation of Hepatic Fibrosis: Preliminary Evaluation against Histopathology and Extracellular Volume Fraction
Open Access
- 29 May 2020
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 10 (2) , 46
Abstract
Background: Evaluate equilibrium contrast-enhanced CT (EQ-CT) texture analysis (EQ-CTTA) against histologically-quantified fibrosis, serum-based enhanced liver fibrosis panel (ELF) and imaging-based extracellular volume fraction (ECV) in chronic hepatitis. Methods: This study was a re-analysis of image data from a previous prospective study. Pre- and equilibrium-phase post-IV contrast CT datasets were collected from patients with chronic hepatitis with contemporaneous liver biopsy and serum ELF measurement between April 2011 and July 2013. Biopsy samples were analysed to derive collagen proportionate area (CPA). EQ-CTTA was performed with a filtration histogram technique using texture analysis software, with texture quantification using statistical and histogram-based metrics (mean, skewness, standard deviation, entropy, etc.). Association between pre-contrast and EQ-CTTA against CPA, ECV and ELF was evaluated using Spearman’s rank correlation coefficient (rs). Results: Complete datasets collected in 29 patients (16 male; 13 female), mean age (range): 49 (22–66 years). Liver ECV, CPA and ELF had a median (interquartile range) of 0.26 (0.24–0.29); 5.0 (3.0–13.7) and 9.71 (8.39–10.92). Difference in segment VII hepatic CTTA (medium texture scale) between EQ-CT and pre-contrast images was significantly and positively associated with ELF score (mean: rs = 0.69, p < 0.001; skewness: rs = 0.57, p = 0.007). Significant negative associations were observed between pre-contrast and EQ-CT whole hepatic CTTA (coarse texture scale) with CPA (pre-contrast, SD: rs = −0.66, p < 0.001) and ECV (EQ-CT, entropy: rs = −0.58, p = 0.006). Conclusions: Hepatic EQ-CTTA demonstrates significant association with validated markers of liver fibrosis, suggesting a role in non-invasive quantification of severity in diffuse fibrosis.Keywords
This publication has 23 references indexed in Scilit:
- NASH Is the Most Rapidly Growing Etiology for Acute‐on‐Chronic Liver Failure‐Related Hospitalization and Disease Burden in the United States: A Population‐Based StudyLiver Transplantation, 2019
- Mechanisms of hepatic stellate cell activationNature Reviews Gastroenterology & Hepatology, 2017
- Texture analysis of the liver at MDCT for assessing hepatic fibrosisAbdominal Radiology, 2017
- Using texture analyses of contrast enhanced CT to assess hepatic fibrosisEuropean Journal of Radiology, 2016
- Equilibrium Contrast-enhanced CT Imaging to Evaluate Hepatic Fibrosis: Initial Validation by Comparison with Histopathologic SamplingRadiology, 2015
- Article Commentary: Mortality Due to Viral Hepatitis in the Global Burden of Disease Study 2010: New Evidence of An Urgent Global Public Health Priority Demanding ActionAntiviral Therapy, 2013
- Worldwide mortality from cirrhosis: An update to 2002Journal of Hepatology, 2007
- Serum markers detect the presence of liver fibrosis: A cohort studyGastroenterology, 2004
- Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infectionAmerican Journal of Gastroenterology, 2002
- Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London.Gut, 1995